Medexus Pharmaceuticals Inc. (TSX:MDP)

Medexus Pharmaceuticals Revenue

Medexus Pharmaceuticals had revenue of $29.99M USD in the quarter ending December 31, 2024, with 18.96% growth. This brings the company's revenue in the last twelve months to $109.54M, down -5.34% year-over-year. In the fiscal year ending March 31, 2024, Medexus Pharmaceuticals had annual revenue of $113.05M with 4.59% growth.

• Revenue (ttm): $109.54M
• Revenue Growth: -5.34%
• P/S Ratio: 0.58
• Revenue / Employee: $1.34M
• Employees: 82
• Market Cap: 91.29M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	113.05M	4.96M	4.59%
Mar 31, 2023	108.10M	31.40M	40.93%
Mar 31, 2022	76.70M	-2.96M	-3.71%
Mar 31, 2021	79.66M	24.15M	43.52%
Mar 31, 2020	55.51M	30.17M	119.07%